Cushman & Wakefield’s 2024 life sciences market report covers national trends and dive deep into top global life sciences markets, for an in-depth look at this quickly changing industry.
REPORT TAKEAWAYS
Life Sciences Sector Trends
The pharmaceutical industry will continue to make strategic investments in AI and M&A to shore up the drug discovery pipeline and make up for the significant loss of exclusivity in the next five years. Additionally, passage of the U.S. Biosecure Act would potentially impact pharmaceutical and biotech supply chains.
Leasing Market Fundamentals
Softer demand has resulted in increased vacancy rates and lower asking rents in some markets. The construction pipeline has declined and no significant new construction is expected until existing projects, and projects under construction, are leased.
Labor
Life sciences labor growth through the next five years will remain robust, and the current construction activity should readily accommodate this demand.
Global Funding
Global life sciences funding in 2024 looks a lot like 2023. Potential interest rate cuts in the second half of the year could spur additional investment in the sector.
Clinical Trials Key Growth Driver
Drug trials continue to dominate the global clinical trials market. FDA approvals are on track to meet or exceed 2023 levels.
Emerging Markets
Discover trends in emerging markets, including inventory growth, inflows of private and public funding and employment growth.
European Markets
A spotlight on European life sciences markets and trends. Recent conditions have been challenging, but the outlook has improved. With medical advances accelerating, new treatments emerging and public sector support strong, activity and interest in the sector is set to increase in the months ahead.
Select each city on the map below to view an in-depth life sciences market summary External Link.
INTERESTED IN MORE?
Read the full report and explore the market-by-market analysis.
Experience the full report
Explore the top markets Subscribe to Life Sciences Insights
Get the latest in Cushman & Wakefield's Life Sciences research and commentary.
Subscribe
Learn More Related Insights
Research
Life Sciences Funding in View
Global life sciences venture capital funding has reverted to its pre-pandemic long-term trend.
Sandy Romero • 1/29/2024
Research
Recent Ups and Downs for the Life Sciences Market
Life sciences tenants searching for space is up over 22% since late spring with activity in real estate grew as well, with over 31 million square feet (sf) of lab and cGMP space leased from 2021 to 2022.
Sandy Romero • 11/8/2023
Article
Energy and Resource Efficiency in Life Sciences Design
Energy- and resource-efficient design can help transform corporate goals for existing life sciences buildings into successful, energy-efficient spaces.
Jason D'Orlando • 9/20/2023